Alfred Kim to Hydroxychloroquine
This is a "connection" page, showing publications Alfred Kim has written about Hydroxychloroquine.
Connection Strength
0.514
-
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Ann Intern Med. 2020 06 02; 172(11):754-755.
Score: 0.154
-
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821.
Score: 0.153
-
Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain? Best Pract Res Clin Rheumatol. 2021 03; 35(1):101658.
Score: 0.040
-
Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'. Expert Rev Clin Immunol. 2021 01; 17(1):105-107.
Score: 0.040
-
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666.
Score: 0.039
-
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis. 2020 10; 79(10):1386-1388.
Score: 0.039
-
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736.
Score: 0.038
-
Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2021 01; 73(1):36-47.
Score: 0.010